Clinical evaluation of Saptavimshatika Guggulu and Haridra Churna in the management of Type-2 Diabetes Mellitus

Type 2 diabetes mellitus is a chronic, debilitating disease characterized by insulin resistance, impaired insulin secretion and hyperglycemia. As per International Diabetes Federation's (IDF) fifth diabetes atlas, India's prevalence of diabetes among 20-79 year olds is 9.2%. India is just second to China. The syndrome of diabetes mellitus is largely covered under the broad heading of Prameha. However, Apathyanimittaja Prameha, Sthula Pramehi and Avaranjanya Madhumeha described in Ayurvedic literature can be correlated with Type-2 Diabetes Mellitus. Aim: to study the effect of Saptavimshatik Guggulu and Haridrachurna in the management of Type 2 Diabetes Mellitus. Material and Methods: recently diagnosed cases of Diabetes Mellitus were treated with Saptavimshatika Guggulu (2 tablet, each of 500 mg) with 1 sachet of Haridra Powder (3 gm) after meal, twice a day with Luke warm water. Total duration of the therapy was 12 weeks. Result: The treatment remained highly significant in for improvement on objective parameter as well as subjective parameter Conclusion: The Drug found more effective in Sthula pramehi (BMI > 25 kg/m2 ) than Krusha pamehi (BMI ≤ 25 kg/m2 ).